{"DataElement":{"publicId":"5775913","version":"1","preferredName":"Mutant Allele Burden Laboratory Procedure Abnormality Detection Outcome","preferredDefinition":"The outcomes associated with the abnormalities detected on the JMML Mutant Allele Burden test.","longName":"ABN_MAB_LAB_PDR_OTCM","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5747257","version":"2","preferredName":"Mutant Allele Burden Laboratory Procedure Abnormality Detection","preferredDefinition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations)._one of a series of possible alternative forms of a given gene, differing in DNA sequence, and affecting the functioning of a single product._The quantity of something that is borne or carried by an individual or population._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A condition that differs from the usual physical or mental state._The activity of perceiving, discerning, discovering or identifying.","longName":"5747254v1.0:5747255v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"5747254","version":"1","preferredName":"Mutant Allele Burden Laboratory Procedure","preferredDefinition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).:one of a series of possible alternative forms of a given gene, differing in DNA sequence, and affecting the functioning of a single product.:The quantity of something that is borne or carried by an individual or population.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C25360:C16277:C85883:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutant","conceptCode":"C25360","definition":"An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Allele","conceptCode":"C16277","definition":"Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Burden","conceptCode":"C85883","definition":"The quantity of something that is borne or carried by an individual or population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CA1114D-C915-3C70-E053-F662850A4BF8","latestVersionIndicator":"Yes","beginDate":"2017-04-08","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-08","modifiedBy":"ONEDATA","dateModified":"2017-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5747255","version":"1","preferredName":"Abnormality Detection","preferredDefinition":"A condition that differs from the usual physical or mental state.:The activity of perceiving, discerning, discovering or identifying.","longName":"C9440:C16210","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4CA1114D-C926-3C70-E053-F662850A4BF8","latestVersionIndicator":"Yes","beginDate":"2017-04-08","endDate":null,"createdBy":"CHANGP","dateCreated":"2017-04-08","modifiedBy":"ONEDATA","dateModified":"2017-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8715A0D1-0A94-2058-E053-F662850AAFA3","latestVersionIndicator":"Yes","beginDate":"2017-04-08","endDate":"2018-11-30","createdBy":"BEELEST","dateCreated":"2019-04-21","modifiedBy":"MAESKEB","dateModified":"2020-06-11","changeDescription":"11/30/2018 - Retired Withdrawn WWL; ADVL1521-PDC. V2.0 released","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5775884","version":"1","preferredName":"Outcome","preferredDefinition":"The result of an action.","longName":"5775884v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Additional acquirement of JMML somatic gene abnormalities","valueDescription":"Acquisition Juvenile Myelomonocytic Leukemia Somatic Cell Genetics Abnormal Additional","ValueMeaning":{"publicId":"5775886","version":"1","preferredName":"Acquisition Juvenile Myelomonocytic Leukemia Somatic Cell Genetics Abnormal Additional","longName":"5775886","preferredDefinition":"The process by which something is acquired or obtained.: A myelodysplastic/myeloproliferative neoplasm of childhood that is characterized by proliferation principally of the granulocytic and monocytic lineages.  Myelomonocytic proliferation is seen in the bone marrow and the blood.  The leukemic cells may infiltrate any tissue, however liver, spleen, lymph nodes, skin, and respiratory tract are the most common sites of involvement. (WHO, 2001): Various methods for gene function studies that rely on the use of cells in culture.: Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: Added; extra; further.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquisition","conceptCode":"C43384","definition":"The process by which something is acquired or obtained.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Juvenile Myelomonocytic Leukemia","conceptCode":"C9233","definition":"A clonal myeloid disorder of childhood previously classified as myelodysplastic/myeloproliferative neoplasm. It is characterized by the presence of monocytic proliferation in peripheral blood, less than 20% blasts in bone marrow and peripheral blood, splenomegaly, and the absence of BCR-ABL1 fusion. Almost all patients carry mutations of the RAS pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Somatic Cell Genetics","conceptCode":"C19037","definition":"Various methods for gene function studies that rely on the use of cells in culture.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D23841C-1CED-424B-E053-F662850AD18C","latestVersionIndicator":"Yes","beginDate":"2017-04-14","endDate":null,"createdBy":"LEEW","dateCreated":"2017-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D60456F-4564-6E8D-E053-F662850A6CAF","beginDate":"2017-04-17","endDate":null,"createdBy":"LEEW","dateCreated":"2017-04-17","modifiedBy":"ONEDATA","dateModified":"2017-04-17","deletedIndicator":"No"},{"value":"Reappearance acquirement of JMML somatic gene abnormalities","valueDescription":"Acquisition Juvenile Myelomonocytic Leukemia Somatic Cell Genetics Abnormal Appearance","ValueMeaning":{"publicId":"5776715","version":"1","preferredName":"Acquisition Juvenile Myelomonocytic Leukemia Somatic Cell Genetics Abnormal Appearance","longName":"5776715","preferredDefinition":"The process by which something is acquired or obtained.: A myelodysplastic/myeloproliferative neoplasm of childhood that is characterized by proliferation principally of the granulocytic and monocytic lineages.  Myelomonocytic proliferation is seen in the bone marrow and the blood.  The leukemic cells may infiltrate any tissue, however liver, spleen, lymph nodes, skin, and respiratory tract are the most common sites of involvement. (WHO, 2001): Various methods for gene function studies that rely on the use of cells in culture.: Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: The outward or visible aspect of a person or thing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquisition","conceptCode":"C43384","definition":"The process by which something is acquired or obtained.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Juvenile Myelomonocytic Leukemia","conceptCode":"C9233","definition":"A clonal myeloid disorder of childhood previously classified as myelodysplastic/myeloproliferative neoplasm. It is characterized by the presence of monocytic proliferation in peripheral blood, less than 20% blasts in bone marrow and peripheral blood, splenomegaly, and the absence of BCR-ABL1 fusion. Almost all patients carry mutations of the RAS pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Somatic Cell Genetics","conceptCode":"C19037","definition":"Various methods for gene function studies that rely on the use of cells in culture.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Appearance","conceptCode":"C25377","definition":"The outward or visible aspect of a person or thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D5FF8DE-0595-6C5F-E053-F662850A6E60","latestVersionIndicator":"Yes","beginDate":"2017-04-17","endDate":null,"createdBy":"LEEW","dateCreated":"2017-04-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D60456F-4578-6E8D-E053-F662850A6CAF","beginDate":"2017-04-17","endDate":null,"createdBy":"LEEW","dateCreated":"2017-04-17","modifiedBy":"ONEDATA","dateModified":"2017-04-17","deletedIndicator":"No"},{"value":"Somatic genetic anomalies detected","valueDescription":"Abnormal Detection Somatic Cell Genetics","ValueMeaning":{"publicId":"5776716","version":"1","preferredName":"Abnormal Detection Somatic Cell Genetics","longName":"5776716","preferredDefinition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: The activity of perceiving, discerning, discovering or identifying.: Various methods for gene function studies that rely on the use of cells in culture.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Somatic Cell Genetics","conceptCode":"C19037","definition":"Various methods for gene function studies that rely on the use of cells in culture.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D5FF8DE-05BC-6C5F-E053-F662850A6E60","latestVersionIndicator":"Yes","beginDate":"2017-04-17","endDate":null,"createdBy":"LEEW","dateCreated":"2017-04-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D60456F-458C-6E8D-E053-F662850A6CAF","beginDate":"2017-04-17","endDate":null,"createdBy":"LEEW","dateCreated":"2017-04-17","modifiedBy":"ONEDATA","dateModified":"2017-04-17","deletedIndicator":"No"},{"value":"Absence of somatic genetic anomalies","valueDescription":"Somatic Cell Genetics Abnormal Absent","ValueMeaning":{"publicId":"5776717","version":"1","preferredName":"Somatic Cell Genetics Abnormal Absent","longName":"5776717","preferredDefinition":"Various methods for gene function studies that rely on the use of cells in culture.: Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.: Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Somatic Cell Genetics","conceptCode":"C19037","definition":"Various methods for gene function studies that rely on the use of cells in culture.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D5FF8DE-05E3-6C5F-E053-F662850A6E60","latestVersionIndicator":"Yes","beginDate":"2017-04-17","endDate":null,"createdBy":"LEEW","dateCreated":"2017-04-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D60456F-45A0-6E8D-E053-F662850A6CAF","beginDate":"2017-04-17","endDate":null,"createdBy":"LEEW","dateCreated":"2017-04-17","modifiedBy":"ONEDATA","dateModified":"2017-04-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D23841C-1CD1-424B-E053-F662850AD18C","latestVersionIndicator":"Yes","beginDate":"2017-04-14","endDate":"2018-11-30","createdBy":"LEEW","dateCreated":"2017-04-14","modifiedBy":"MAESKEB","dateModified":"2020-06-11","changeDescription":"11/30/2018 - Retired Withdrawn WWL; Workflow and Registration Status Changed per Brenda Duggan; 05.16.18; ADVL1521 - WWL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Are there abnormalities detec","type":"Preferred Question Text","description":"Are there abnormalities detected on the JMML Mutant Allele Burden test?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D269E23-104A-06BC-E053-F662850AE07D","latestVersionIndicator":"Yes","beginDate":"2020-06-01","endDate":"2018-11-26","createdBy":"LEEW","dateCreated":"2017-04-14","modifiedBy":"MAESKEB","dateModified":"2020-06-11","changeDescription":"11/26/2018 - Retired Withdrawn WWL;  Workflow and Registration Status Changed per Brenda Duggan; 05.16.18; ADVL1521 - WWL; reactivated with new DEC v2.  06/01/2020; updated DEC, VD and CDE for compliance bsm.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}